These features may be correlated to the overexpression of drug resistance genes such as BCRP1 and DNA-mismatch repair genes such as MGMT, as well as genes related to inhibiting cell apoptosis on CD133 positive cancer stem cells. This evidence concerns the gene BCRP1 and cancer.